Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 3
1981 3
1982 2
1983 2
1984 1
1985 1
1986 6
1987 5
1988 7
1989 2
1990 3
1991 8
1992 5
1993 6
1994 8
1995 15
1996 15
1997 11
1998 21
1999 21
2000 20
2001 24
2002 29
2003 39
2004 29
2005 46
2006 51
2007 59
2008 81
2009 84
2010 93
2011 100
2012 129
2013 151
2014 209
2015 248
2016 260
2017 282
2018 317
2019 380
2020 424
2021 540
2022 643
2023 620
2024 670
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,096 results

Results by year

Filters applied: . Clear all
Page 1
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Ren Z, Xu J, Bai Y, Xu A, Cang S, Du C, Li Q, Lu Y, Chen Y, Guo Y, Chen Z, Liu B, Jia W, Wu J, Wang J, Shao G, Zhang B, Shan Y, Meng Z, Wu J, Gu S, Yang W, Liu C, Shi X, Gao Z, Yin T, Cui J, Huang M, Xing B, Mao Y, Teng G, Qin Y, Wang J, Xia F, Yin G, Yang Y, Chen M, Wang Y, Zhou H, Fan J; ORIENT-32 study group. Ren Z, et al. Among authors: du c. Lancet Oncol. 2021 Jul;22(7):977-990. doi: 10.1016/S1470-2045(21)00252-7. Epub 2021 Jun 15. Lancet Oncol. 2021. PMID: 34143971 Clinical Trial.
Propionibacterium acnes strain populations in the human skin microbiome associated with acne.
Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, Modlin RL, Miller JF, Sodergren E, Craft N, Weinstock GM, Li H. Fitz-Gibbon S, et al. Among authors: du c. J Invest Dermatol. 2013 Sep;133(9):2152-60. doi: 10.1038/jid.2013.21. Epub 2013 Jan 21. J Invest Dermatol. 2013. PMID: 23337890 Free PMC article.
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.
Wen X, Xu P, Zeng X, Liu J, Du C, Zeng X, Cheng X, Wang X, Liang Y, Zhao T, Yang H, Li H, Meng L, Fang J, Liu H, Zhou Z, Zhang J, Zhang X, Guo Z, Chen X. Wen X, et al. Among authors: du c. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2846-2860. doi: 10.1007/s00259-023-06229-w. Epub 2023 Apr 25. Eur J Nucl Med Mol Imaging. 2023. PMID: 37097443
Graph-Enhanced Emotion Neural Decoding.
Huang Z, Du C, Wang Y, Fu K, He H. Huang Z, et al. Among authors: du c. IEEE Trans Med Imaging. 2023 Aug;42(8):2262-2273. doi: 10.1109/TMI.2023.3246220. Epub 2023 Aug 1. IEEE Trans Med Imaging. 2023. PMID: 37027550
Targeting m6A binding protein YTHDFs for cancer therapy.
Zhang W, Wu T, Zhang Y, Kang W, Du C, You Q, Chen X, Jiang Z. Zhang W, et al. Among authors: du c. Bioorg Med Chem. 2023 Jul 15;90:117373. doi: 10.1016/j.bmc.2023.117373. Epub 2023 Jun 12. Bioorg Med Chem. 2023. PMID: 37329678 Review.
5,096 results